Biobeat

Company profile

About Biobeat

Biobeat is revolutionizing hypertension care through its groundbreaking cuffless ambulatory blood pressure monitoring (ABPM) system. The company's FDA-cleared, medical-grade chest patch enables continuous 24-hour blood pressure monitoring without the discomfort and sleep disruption of traditional cuff-based systems. Using proprietary patented PPG (photoplethysmography) sensor technology, Biobeat's wireless monitoring solution addresses critical gaps in hypertension diagnosis and management, including white coat syndrome and masked hypertension. The system automatically generates comprehensive reports that provide clinicians with crucial insights into patients' blood pressure patterns throughout day and night, enabling more effective treatment planning and better patient outcomes. Biobeat's approach eliminates patient anxiety associated with traditional monitoring methods while improving compliance through enhanced comfort. The company serves cardiologists, nephrologists, and hypertension centers across major health systems in the United States and is expanding internationally. Validated against gold standard cuff-based monitoring and published in the American Journal of Hypertension, Biobeat's solution supports ACC/AHA guideline recommendations for 24-hour monitoring to confirm hypertension diagnosis. The company is driven by a mission to ensure all hypertension patients are monitored and managed effectively, leveraging the latest advancements in wearable technology and data analytics to transform healthcare delivery.

Company description · Biobeat official website